Scholtz & Company, LLC Insulet Corp Transaction History
Scholtz & Company, LLC
- $207 Million
- Q3 2024
A detailed history of Scholtz & Company, LLC transactions in Insulet Corp stock. As of the latest transaction made, Scholtz & Company, LLC holds 8,411 shares of PODD stock, worth $2.24 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
8,411
Previous 9,151
8.09%
Holding current value
$2.24 Million
Previous $1.85 Million
6.01%
% of portfolio
0.95%
Previous 0.79%
Shares
2 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.6MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.26 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.07 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.62 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$777 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$607 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...